Red blood cells are crucial for oxygen transport, powered by hemoglobin. Genetic disorders like sickle cell disease and thalassemias lead to severe complications due to faulty genes. Gene editing offers hope for treatment, targeting mutations effectively. Challenges remain in delivery and immune response, but advancements could transform lives afflicted by these conditions.